All In Biotech

Drug Trial Radar · NCT03078478

A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs

Last checked: Nov 20, 2026Latest source record: Jan 11, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,609 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,609

Actual

Start

Mar 13, 2017

Primary completion

Feb 13, 2019

Study completion Mar 4, 2019

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Mar 13, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial is conducted in Europe and North America. The aim of the trial is to compare the efficacy and safety of insulin degludec and insulin glargine 300 units/mL in subjects with type 2 diabetes mellitus inadequately treated with basal insulin with or without oral antidiabetic drugs. Due to change in glycaemic data collection process, this trial is amended to allow for a full 36 weeks (maintenance 2 period) of the use of the new process.

Conditions

  • Diabetes
  • Diabetes Mellitus, Type 2

Interventions

  • Insulin degludecDrug

    For subcutaneous (s.c., under the skin) injection once daily

  • Insulin glargineDrug

    For subcutaneous (s.c., under the skin) injection once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Severe or BG-confirmed Symptomatic Hypoglycaemic Episodes During Maintenance 2 (36 Weeks)Time frame: 36 Weeks

Locations

229 sites in 12 countries. Site status is shown where the registry gives one.

  • Novo Nordisk Investigational Site

    Anniston, Alabama

  • Novo Nordisk Investigational Site

    Birmingham, Alabama

  • Novo Nordisk Investigational Site

    Chandler, Arizona

  • Novo Nordisk Investigational Site

    Fountain Hills, Arizona

  • Novo Nordisk Investigational Site

    Glendale, Arizona

  • Novo Nordisk Investigational Site

    Glendale, Arizona

  • Novo Nordisk Investigational Site

    Glendale, Arizona

  • Novo Nordisk Investigational Site

    Phoenix, Arizona

  • Novo Nordisk Investigational Site

    Tucson, Arizona

  • Novo Nordisk Investigational Site

    Buena Park, California

  • Novo Nordisk Investigational Site

    Concord, California

  • Novo Nordisk Investigational Site

    Downey, California

  • Novo Nordisk Investigational Site

    Duarte, California

  • Novo Nordisk Investigational Site

    Fresno, California

  • Novo Nordisk Investigational Site

    La Jolla, California

  • Novo Nordisk Investigational Site

    Lancaster, California

  • Novo Nordisk Investigational Site

    Lomita, California

  • Novo Nordisk Investigational Site

    Los Alamitos, California

  • Novo Nordisk Investigational Site

    Los Angeles, California

  • Novo Nordisk Investigational Site

    Moreno Valley, California

  • Novo Nordisk Investigational Site

    Northridge, California

  • Novo Nordisk Investigational Site

    Palm Springs, California

  • Novo Nordisk Investigational Site

    Pomona, California

  • Novo Nordisk Investigational Site

    Poway, California

  • Novo Nordisk Investigational Site

    Riverside, California

  • Novo Nordisk Investigational Site

    Roseville, California

  • Novo Nordisk Investigational Site

    Sacramento, California

  • Novo Nordisk Investigational Site

    San Mateo, California

  • Novo Nordisk Investigational Site

    San Ramon, California

  • Novo Nordisk Investigational Site

    Stanford, California

  • Novo Nordisk Investigational Site

    Vista, California

  • Novo Nordisk Investigational Site

    Walnut Creek, California

  • Novo Nordisk Investigational Site

    West Hills, California

  • Novo Nordisk Investigational Site

    Colorado Springs, Colorado

  • Novo Nordisk Investigational Site

    Englewood, Colorado

  • Novo Nordisk Investigational Site

    Waterbury, Connecticut

  • Novo Nordisk Investigational Site

    Bradenton, Florida

  • Novo Nordisk Investigational Site

    Brandon, Florida

  • Novo Nordisk Investigational Site

    Clearwater, Florida

  • Novo Nordisk Investigational Site

    Cooper City, Florida

Showing 40 of 229 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.